AMG to Announce Third Quarter Results on November 9, 2015

Teleconference Scheduled for 8:00 a.m. Eastern Time

BOSTON--(BUSINESS WIRE)-- Affiliated Managers Group, Inc. (NYSE: AMG) will report financial and operating results for the third quarter ended September 30, 2015 on Monday, November 9, 2015. A teleconference will be held at 8:00 a.m. Eastern time on the same day.

In addition to quarterly results, the teleconference may include discussion of management’s expectations of future financial and operating results. Sean M. Healey, Chairman and Chief Executive Officer, Nathaniel Dalton, President and Chief Operating Officer, and Jay C. Horgen, Chief Financial Officer, will host the session.

Parties interested in listening to the teleconference should dial 1-877-407-8291 (U.S. calls) or 1-201-689-8345 (non-U.S. calls) starting at 7:45 a.m. Eastern time. Those wishing to listen to the teleconference should dial the appropriate number at least ten minutes before the call begins.

The teleconference will also be available for replay beginning approximately one hour after the conclusion of the call. To hear a replay of the call, please dial 1-877-660-6853 (U.S. calls) or 1-201-612-7415 (non-U.S. calls) and provide conference ID 13624300. The live call and replay of the session, and additional financial information referenced during the teleconference, can also be accessed via AMG’s website at http://www.amg.com/InvestorRelations/.

For more information on AMG, please visit www.amg.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151030005987/en/

Investor and Media Relations:
Alexandra Lynn
Selene Oh
(617) 747-3300
[email protected]
[email protected]

Source: Affiliated Managers Group, Inc.

You May Also Be Interested In

• Old National Releases 2023 ESG Report
• Print Three Recognized for Franchise Excellence at CFA National Convention
• Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market